Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
7.810
+0.460 (+6.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Cathie Wood's Ark Invest Buys $16M Worth Of Shares Of Flying Taxi Company Archer Aviation — Sells Shopify Stock Worth Millions
August 16, 2023
Via
Benzinga
These 9 AI Stocks Are Up 95%, On Average, Since End Of April
August 13, 2023
Nine artificial intelligence and AI-related stocks, with market caps in excess of $2B, have advanced by +60% since the bubble began to develop at the end of April into early May, with an average...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Every AI Stock Cathie Wood Owns, Ranked From Best to Worst
August 12, 2023
You can find some great AI investment opportunities by looking at the stocks in Wood's Ark Invest portfolio.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Things About Recursion Pharmaceuticals That Smart Investors Know
August 11, 2023
Until it can get some recurring revenue going, it'll be a risky stock to buy.
Via
The Motley Fool
Analyst Expectations for Recursion Pharmaceuticals's Future
August 09, 2023
Via
Benzinga
3 AI Stocks You’ll Regret Not Buying Soon
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
August 08, 2023
Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances...
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Via
Benzinga
2 Healthcare AI Stocks That Could Go Parabolic
August 02, 2023
Shares of Recursion Pharmaceuticals and GE Healthcare are both up sharply so far this year.
Via
The Motley Fool
Recursion to Participate in Upcoming Investor Conference
August 01, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
August 01, 2023
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
These 10 AI Stocks Are Up An Average Of 99% In Last 3 Months
July 30, 2023
Ten artificial intelligence and AI-related (AI&R) stocks, with market capitalizations of +$1.5B, have advanced by 70% or more (average of 99%!) since the bubble began to develop at the end of April....
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
July 28, 2023
Via
Benzinga
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
July 28, 2023
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
July 27, 2023
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia’s AI Explosion: What NVDA Stock Investors Need to Know Now
July 27, 2023
Rather than sell your Nvidia shares, diversify. That's what the Cloud Czars want to do. They'll save, and you'll profit.
Via
InvestorPlace
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
July 26, 2023
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic...
From
Recursion Pharmaceuticals
Via
GlobeNewswire
These 26 AI Stocks Are Up 58% In Just 11 Weeks
July 24, 2023
The Bank of America suggests that this is just a
Via
Talk Markets
MarketBeat Week in Review – 7/17 - 7/21
July 22, 2023
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
July 21, 2023
They're not guaranteed to keep soaring, but they are right now.
Via
The Motley Fool
Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?
July 19, 2023
Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week.
Via
InvestorPlace
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
July 19, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why It May Not Be Too Late to Join Nvidia’s Sky-High AI Rally
July 19, 2023
As long as Nvidia is a darling of the market - and as long as the company invests in future-facing technology - NVDA stock has room to run.
Via
InvestorPlace
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
July 18, 2023
Both companies could tap into huge growth from the AI revolution in a few years.
Via
The Motley Fool
NVIDIA Just Invested $50 Million in This Biotech -- Should You Buy It?
July 18, 2023
Gaining one of the world's most important AI companies as a collaborator is huge.
Via
The Motley Fool
NVDA Stock Update: What Nvidia Investors Need to Be Watching Now
July 18, 2023
With Nvidia still the best option for long-term investors looking to take advantage of the AI race, here's what to watch.
Via
InvestorPlace
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
July 17, 2023
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.
Via
Talk Markets
Nvidia Invested $50 million into This AI Drug Discovery Biotech
July 17, 2023
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Biotech Stocks Using AI to Change Healthcare Forever
July 14, 2023
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past.
Via
InvestorPlace
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.